Remove 2028 Remove Governance Remove Informed Consent Remove Licensing
article thumbnail

SQA Regulatory Surveillance Summary | Monthly Update 2023 – January

SQA

It includes aspects such as home health visits, remote monitoring and diagnostics, direct-to-patient shipment of study drugs, and electronic informed consent. There were seven (7) observations with respect to the following: Quality Control Department: The establishment and/or the maintenance of a data governance plan was inadequate.